Skip to search formSkip to main contentSkip to account menu

xylocydine

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Synthesis of 6-(het) ary Xylocydine analogues and evaluating their inhibitory activities of CDK1 and CDK2 in vitro.
2010
2010
Xylocydine, a novel Cdk inhibitor, is an effective inducer of apoptosis in hepatocellular carcinoma cells in vitro and in vivo.
2009
2009
Xylocydine, a novel Cdk inhibitor, is an effective inducer of apoptosis in human hepatocellular carcinoma cells in vitro and in vivo
Review
2008
Review
2008
Research Progress on Synthesis of Xylocydine--a Novel Inhibitor of Cyclin-Dependent Kinases
Xylocydine is a novel inhibitor of cyclin-dependent kinases,it's discovery and bioactivity are introduced and the recent progress… 
2008
2008
Xylocydine, a specific CDK 12 inhibitor more sensitively induces apoptosis of hepatoma cells that are abnormally upregulated in their cellular CDK 12 activity
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)